June 15, 2017
Patients with severe and end-stage heart failure have few treatment options available to them apart from transplants and "miraculous" stem cell therapy. But a new Tel Aviv University study finds that stem cell therapy may, in fact, harm heart disease patients.
The research, led by Prof. Jonathan Leor of TAU's Sackler Faculty of Medicine and Sheba Medical Center and conducted by TAU's Dr. Nili Naftali-Shani, explores the current practice of using cells from the host patient to repair tissueand contends that this can prove deleterious or toxic for patients. The study was recently published in the journal Circulation.
"We found that, contrary to popular belief, tissue stem cells derived from sick hearts do not contribute to heart healing after injury," said Prof. Leor. "Furthermore, we found that these cells are affected by the inflammatory environment and develop inflammatory properties. The affected stem cells may even exacerbate damage to the already diseased heart muscle."
Tissue or adult stem cells"blank" cells that can act as a repair kit for the body by replacing damaged tissueencourage the regeneration of blood vessel cells and new heart muscle tissue. Faced with a worse survival rate than many cancers, many heart failure patients have turned to stem cell therapy as a last resort.
"But our findings suggest that stem cells, like any drug, can have adverse effects," said Prof. Leor. "We concluded that stem cells used in cardiac therapy should be drawn from healthy donors or be better genetically engineered for the patient."
Hope for improved cardiac stem cell therapy
In addition, the researchers also discovered the molecular pathway involved in the negative interaction between stem cells and the immune system as they isolated stem cells in mouse models of heart disease. After exploring the molecular pathway in mice, the researchers focused on cardiac stem cells in patients with heart disease.
The results could help improve the use of autologous stem cellsthose drawn from the patients themselvesin cardiac therapy, Prof. Leor said.
"We showed that the deletion of the gene responsible for this pathway can restore the original therapeutic function of the cells," said Prof. Leor. "Our findings determine the potential negative effects of inflammation on stem cell function as they're currently used. The use of autologous stem cells from patients with heart disease should be modified. Only stem cells from healthy donors or genetically engineered cells should be used in treating cardiac conditions."
The researchers are currently testing a gene editing technique (CRISPER) to inhibit the gene responsible for the negative inflammatory properties of the cardiac stem cells of heart disease patients. "We hope our engineered stem cells will be resistant to the negative effects of the immune system," said Prof. Leor.
Explore further: Adult stem cell types' heart repair potential probed
More information: Nili Naftali-Shani et al, Left Ventricular Dysfunction Switches Mesenchymal Stromal Cells Toward an Inflammatory Phenotype and Impairs Their Reparative Properties Via Toll-Like Receptor-4Clinical Perspective, Circulation (2017). DOI: 10.1161/CIRCULATIONAHA.116.023527
Journal reference: Circulation
Provided by: Tel Aviv University
New University of Otago research is providing fresh insights into how a patient's adult stem cells could best be used to regenerate their diseased hearts.
Genetically engineered human cardiac stem cells helped repair damaged heart tissue and improved function after a heart attack, in a new animal study.
Scientists use mathematical modeling to simulate human mesenchymal stem cell delivery to a damaged heart and found that using one sub-set of these stem cells minimises the risks associated with this therapy. The study, published ...
An international team of researchers, funded by Morris Animal Foundation, has shown that adipose (fat) stem cells might be the preferred stem cell type for use in canine therapeutic applications, including orthopedic diseases ...
A*STAR researchers and colleagues have developed a method to isolate and expand human heart stem cells, also known as cardiac progenitor cells, which could have great potential for repairing injured heart tissue.
(HealthDay)A new method for delivering stem cells to damaged heart muscle has shown early promise in treating severe heart failure, researchers report online July 27 in Stem Cells Translational Medicine.
Researchers at Karolinska Institutet in Sweden have obtained the first 3D snapshots of a sperm protein attached to a complementary egg coat protein at the beginning of fertilisation. The study, which reveals a common egg ...
As we bask in the summer heat, it is easy to take for granted that humans are also prepared for the cold of winter, with overcoats in the closet and home heating systems ready to be fired up as an added assurance against ...
Organs-on-Chips (Organ Chips) are emerging as powerful tools that allow researchers to study the physiology of human organs and tissues in ways not possible before. By mimicking normal blood flow, the mechanical microenvironment, ...
Monash University's Biomedicine Discovery Institute (BDI) researchers have collaboratively developed a therapeutic approach that dramatically promotes the growth of muscle mass, which could potentially prevent muscle wasting ...
As a molecular biologist, Kaori Noridomi gets an up-close view of the targets of her investigations. But when she began studying the molecular structures of a rarely diagnosed autoimmune disorder, myasthenia gravis, she decided ...
Researchers from Imperial College London and colleagues have found a potential way to target the receptors that specifically control appetite in mouse brains, potentially without causing other side effects.
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Read the original here:
Cardiac stem cells from heart disease patients may be harmful - Medical Xpress
- Artificial embryo without sperm or egg forms live fetus - ZME Science - October 21st, 2019
- Novel Cell Sorting and Separation Markets, 2030 - Yahoo Finance - October 7th, 2019
- Platelet BioGenesis Receives Contract Worth Up to $56 Million from the Biomedical Advanced Research and Development Authority (BARDA) to Develop Human... - October 7th, 2019
- Researchers identify molecular process that could accelerate recovery from nerve injuries - UCLA Newsroom - October 7th, 2019
- A Therapeutic Counterblow to Traumatic Brain Injury - Technology Networks - October 7th, 2019
- American Cancer Society research breakfast highlights Colorado innovations changing the face of cancer care - The Know - October 7th, 2019
- UW Medicine receives $50 million donation to start brain institute - Lewiston Morning Tribune - October 5th, 2019
- UW Medicine receives $50 million donation to start institute to study addiction, Alzheimer's and more - The Daily World - October 5th, 2019
- American CryoStem Expands Investigator Team with Sub-Investigators for Post Concussive Syndrome IND - Yahoo Finance - October 5th, 2019
- UW Medicine receives $50 million donation to start brain institute that will study addiction, Alzheimers and other brain disorders - Seattle Times - October 3rd, 2019
- Tenaya Therapeutics bags $92M to develop triple threat for heart disease - FierceBiotech - October 3rd, 2019
- Opinion: Primate research is cruel, expensive, unnecessary and happening here - OregonLive.com - October 3rd, 2019
- Giving a Speed Boost to Nerve Regrowth - Technology Networks - October 3rd, 2019
- Walking in His Shoes - Curetoday.com - October 3rd, 2019
- Into the Future With CAR-T Cell Therapy - Curetoday.com - October 3rd, 2019
- American CryoStem Expands Investigator Team with Sub-Investigators for Post Concussive Syndrome IND - GuruFocus.com - October 3rd, 2019
- Oncternal Therapeutics Announces Opening of Phase 1b Expansion Cohort of Clinical Trial of Cirmtuzumab in Combination with Ibrutinib in Patients with... - October 3rd, 2019
- Skin-Cells-Turned-to-Heart-Cells Help Unravel Genetic Underpinnings of Cardiac Function - UC San Diego Health - October 1st, 2019
- AIVITA Biomedical to Present at Meeting on the Mesa and Other Investor, Oncology and Regenerative Medicine Conferences in October - PRNewswire - October 1st, 2019
- 3 Houston innovators to know this week - InnovationMap - October 1st, 2019
- Cord Stem Cell banking Market is Growing at a CAGR of 22.4% by Market Share and Growth with Top Key Players: National Cord Blood Program, Vita 34,... - September 24th, 2019
- How Cells Maintain Their Identity - Technology Networks - September 24th, 2019
- Mayo Clinic Q&A: Bone marrow transplants save lives more donors are needed - TribLIVE - September 24th, 2019
- After 'Hail Mary,' Leukemia Patient is in Remission With Help of Donor - Dana-Farber Cancer Institute - September 24th, 2019
- September Is Pediatric Cancer Awareness Month - Newswise - September 24th, 2019
- Guest view: Editors untimely death shines light on rare, incurable disease amyloidosis - Stockton Record - September 24th, 2019
- Steve Hunt's untimely death shines light on rare, incurable disease - VVdailypress.com - September 24th, 2019
- How to Get the Most from Stem Cell Therapy - Medical Center - September 16th, 2019
- Stem Cell Rejuvenation Center > About Us - September 16th, 2019
- Stem Cell Therapy Atlanta Home - Southern Stem Cell Institute - May 21st, 2019
- Dr. Bermans's Stem Cell Therapy - Mark Berman MD - May 17th, 2019
- Stem Cell Therapy | Lighthouse Medical Center ... - April 25th, 2019
- Braselton Georgia Stem Cell Therapy - Revive Medical Center - April 25th, 2019
- The Spine Center: Stem Cell | Charles Theofilis, M.D. - March 9th, 2019
- Stem Cell Therapy in Dallas, TX | National Stem Cell Centers - March 6th, 2019
- Stem Cell Therapy in Dallas, TX - atlasmedicalcenter.com - March 1st, 2019
- Innovative Medical Center: Stem Cell Clinic, Chiropractic ... - February 20th, 2019
- Stem Cells - The Hastings Center - January 29th, 2019
- Stem Cell Therapy Specialist - Columbia, MO: Renova ... - January 4th, 2019
- Stem Cell Therapy Kennewick Medical Center - December 29th, 2018
- Umbilical Stem Cell Hino Medical Center - December 7th, 2018
- Stem Cells Doctors at StemCells21 Medical Center | Adult ... - November 13th, 2018
- Stem Cell Therapy - Fresno, CA: Innovative Medical Center - November 8th, 2018
- Oregon Regenerative Stem Cell Medical Center: Regenerative ... - October 7th, 2018
- Stem Cell Therapy - Genesis Medical Center - October 3rd, 2018
- Stem Cell Therapy in Dallas, TX | Atlas Medical Center - September 6th, 2018
- Stem Cell Research Hino Medical Center - August 20th, 2018
- Stem Cell Therapy - Revive Medical Center - July 27th, 2018
- Stem Cell Medical Centers - Global Stemcell Therapy - July 25th, 2018
- Atlas Medical Center Provides Stem Cell Therapy for Knee ... - July 25th, 2018
- Stem Cell Therapy - Cendant Stem Cell Center - Denver ... - July 22nd, 2018
- Regenexx Overview - Health Link Medical Center - July 14th, 2018
- Stem Cell Therapy in Mexico - Official Treatment Center - July 11th, 2018
- Stem Cells Medical Center - StemCells21 in Bangkok - July 7th, 2018
- Regenerative Stem Cell Therapy Specialist - Zanesville, OH ... - July 7th, 2018
- Stem Cell Therapy And Regenerative Medicine : Midwest ... - July 5th, 2018
- Del Prado Stem Cell Center - Tijuana - July 4th, 2018
- Stem Cell Therapy | Life Health Medical Center | Salt Lake ... - July 1st, 2018
- Stem Cell Center Of NJ - New Jersey Stem Cell Therapy - October 6th, 2017
- Stem Cell Transplants | MD Anderson Cancer Center - September 24th, 2017
- Northern California Stem Cell Treatment Center in Redding, CA - September 22nd, 2017
- Researchers Hope Zika Virus Can Treat Deadly Brain Cancer - Healthline - September 8th, 2017
- 'Nanotransfection' Turns Animal Skin into Blood Vessels and Brain Cells - Medical Device and Diagnostics Industry - September 8th, 2017
- Dr. Pawel Muranski to Head New Cellular Immunotherapy Laboratory at NewYork-Presbyterian/Columbia University ... - Newswise (press release) - August 31st, 2017
- FDA announces first US gene therapy approval for cancer treatment - CNN - August 31st, 2017
- 'Reprogrammed' Stem Cells Fight Parkinson's Disease in Monkeys - Voice of America - August 31st, 2017
- CSL Behring pays $91M upfront for early stage gene therapy - BioPharma Dive - August 30th, 2017
- Frawley, Mindell/Brody, Calkins Awards Recognize 5 for Excellence - UB School of Medicine and Biomedical Sciences News - August 30th, 2017
- FDA Cracks Down on 'Unscrupulous' Stem Cell Clinics - New York Times - August 29th, 2017
- Creative Medical Technology Holdings Achieves 100% Patient ... - Markets Insider - August 29th, 2017
- BACK IN ACTION: Stem Cell Knee Procedure Gets Middle Aged Athlete Back On Slopes, Court - SpaceCoastDaily.com - August 28th, 2017
- Bait and Switch - Stem Cell Treatments and Insurance ... - August 28th, 2017
- 2 patients contract Legionnaires' Disease at UW Medical Center - KING5.com - August 28th, 2017
- Twin Falls multiple sclerosis patients are traveling to get new treatment - Coeur d'Alene Press - August 28th, 2017
- As Blumen fights cancer, city creates awareness on stem cell donation - Times of India - August 27th, 2017
- Mayo, U develop 'robocop' stem cells to fight cancer - StarTribune.com - Minneapolis Star Tribune - August 20th, 2017
- Scientists Discover New Hair Growth Technique Using Stem Cells - TrendinTech - August 20th, 2017
- Could Newborn Heart Stem Cells Jump-Start Old Hearts? - Sioux City Journal - August 20th, 2017
- Linking seizures, heart health and sleeping sickness to bacteria and shape-shifting parasites in the mouth and gut - UB News Center - August 17th, 2017
- Vitamin C may encourage blood cancer stem cells to die - Medical Xpress - August 17th, 2017